Orna Therapeutics

company

About

Orna Therapeutics is a biotechnology company that specializes in fully engineered circular RNA therapeutics to treat various diseases.

  • 51 - 100

Details

Last Funding Type
Series A
Last Funding Money Raised
$80M
Industries
Biotechnology,Medical,Pharmaceutical,Therapeutics
Founded date
Jan 1, 2019
Number Of Employee
51 - 100
Operating Status
Active

Orna Therapeutics is a biotechnology company dedicated to designing and delivering a new class of fully engineered circular RNA (oRNA) therapeutics with the potential to change the way we treat disease.

The company's proprietary platform combines novel technology to create oRNAs that drive protein expression with validated and unique delivery solutions.

Orna Therapeutics was established in 2019 by Alex Wesselhoeft and Raffaella Squilloni in Cambridge, Massachusetts.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$80M
Orna Therapeutics has raised a total of $80M in funding over 2 rounds. Their latest funding was raised on Feb 24, 2021 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Feb 24, 2021 Series A $80M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Orna Therapeutics is funded by 1 investors. Kite Pharma are the most recent investors.
Investor Name Lead Investor Funding Round
Kite Pharma Series A